D. Gong et al. / Journal of Organometallic Chemistry 702 (2012) 10e18
17
C13H13N5Fe56Cl335 (relative ratio): (m/z) 365 (mþ, ꢀCl), 330
(mþ, ꢀ2Cl).
4.3.12. 2,6-bis(3,5-dimethylpyrazoyl)pyridine iron(II)Cl2 (4c)
The procedure as above in (4.3.1) using L6 and FeCl2 gave 4c as
a yellow powder in 81.7% yield.
IR (KBr, cmꢀ1): 3100, 2925, 1613, 1562, 1479, 1393, 1363, 1309,
4.3.6. 2,6-bis(3,5-dimethylpyrazoyl)pyridine iron(III)Cl2 (2c)
The procedure as above in (4.3.1) using L6 and FeCl3 gave 2c as
a red powder in 91.7% yield.
1182, 1136, 1047, 985, 846, 788, 739. 1H NMR (400 MHz, CDCl3):
d
(ppm) 8.05 (1H, Hpyr), 7.67 (2H, Hpyr), 6.14 (2H, Hpyz), 2.21 (12H,
IR (KBr, cmꢀ1): 3108, 3001, 1613, 1591, 1561, 1483, 1472, 1419,
eCH3). Anal. Calcd. for C15H17N5FeCl2: C, 45.72; H, 4.35; N, 17.77.
Found: C, 44.89; H, 4.12; N, 18.41. MALDIeTof for C15H17N5Fe56Cl235
(relative ratio): (m/z) 394 (mþ, ꢀCl), 358 (mþ, ꢀ2Cl).
1393, 1362, 1315, 1302, 1182, 1138, 1051, 986, 813, 791, 741. 1H NMR
(400 MHz, CDCl3): d (ppm) 8.06 (1H, Hpyr), 7.67 (2H, Hpyr), 6.14 (2H,
Hpyz), 2.21 (12H, eCH3). Anal. Calcd. for C15H17Cl3N5Fe: C, 41.94; H,
3.99; N, 16.30. Found: C, 39.89; H, 3.72; N, 17.63. MALDIeTof for
C15H17N5Fe56Cl335 (relative ratio): (m/z) 393 (mþ, ꢀCl), 358
(mþ, ꢀ2Cl).
4.3.13. 2,6-bis(benzimidazol-2-yl)pyridine cobalt(II)Cl2 (5a)
The procedure as above in (4.3.1) using L1 and CoCl2 gave 5a as
a green powder in 85% yield.
IR (KBr, cmꢀ1): 3061(vNeH), 1607 (vC]N), 1691(vC]C), 1575, 1494,
1459 (dNeH), 1317, 1234, 1147, 996, 819, 744 (dNeH). Anal. Calcd. for
C19H13N5CoCl2: C, 51.73; H, 2.97; N, 15.87. Found: C, 51.24; H, 3.35;
N, 14.10. MALDIeTof for C19H13N5Co58Cl235 (relative ratio): (m/z) 405
(mþ, ꢀCl), 369 (mþ, ꢀ2Cl).
4.3.7. 2,6-bis(benzimidazol-2-yl)pyridine iron(II)Cl2 (3a)
The procedure as above in (4.3.1) using L1 and FeCl2 gave 3a as
a dark blue powder in 85% yield.
IR (KBr, cmꢀ1): 3195, 3046 (vNeH),1608 (vC]C),1577 (vC]N),1495
(
dNeH), 1493, 1443, 1317, 1237, 1147, 994, 820, 748 (dNeH). 1H NMR
4.3.14. 2,6-bis(10-ethylbenzimidazol-20-yl)pyridine
cobalt(II)Cl2 (5b)
The procedure as above in (4.3.1) using L2 and CoCl2 gave 5b as
a green powder in 85% yield.
(400 MHz, CDCl3): d (ppm) 8.35 (2H, Hpyr), 8.19 (1H, Hpyr), 7.76 (4H,
Hph), 7.32 (4H, Hph). Anal. Calcd. for C19H13N5FeCl2: C, 52.09; H,
2.99; N, 15.99. Found: C, 52.16; H, 2.98; N, 15.95. MALDIeTof for
C19H13N5Fe56Cl335 (relative ratio): (m/z) 437 (mþ), 402 (mþ, -Cl).
IR (KBr, cmꢀ1): 3020, 2987, 2935, 1600 (vC]C), 1573 (vC]N), 1512,
1485, 1460, 1443, 1349, 1335, 1154, 1094, 812, 762, 749. Anal. Calcd.
for C23H21N5CoCl2: C, 55.55; H, 4.26; N, 14.08. Found: C, 54.48; H,
4.31; N, 12.94. MALDIeTof for C23H21N5Fe56Cl235 (relative ratio):
(m/z) 461 (mþ, ꢀCl).
4.3.8. 2,6-bis(10-ethylbenzimidazol-20-yl)pyridine iron(II)Cl2 (3b)
The procedure as above in (4.3.1) using L2 and FeCl2 gave 3b as
a dark blue powder in 85% yield.
IR (KBr, cmꢀ1): 2933, 2872, 1600 (vC]C), 1570 (vC]N), 1507, 1460
(
dNeH), 1484, 1460, 1441, 1417, 1349, 1335, 1135, 1095, 873, 810, 761,
748. Anal. Calcd. for C23H21N5FeCl2: C, 55.90; H, 4.28; N, 14.17. 1H
NMR (400 MHz, CDCl3): (ppm) 8.37 (2H, Hpyr), 8.25 (1H, Hpyr), 7.76
4.3.15. 2,6-bis(10-benzylbenzimidazol-20-yl)pyridine
cobalt(II)Cl2 (5c)
The procedure as above in (4.3.1) using L3 and CoCl2 gave 5c as
a green powder in 85% yield.
d
(4H, Hph), 7.34 (4H, Hph), 1.32 (6H, eCH3). Found: C, 55.21; H, 4.29;
N,14.44. MALDIeTof for C23H21N5Fe56Cl235 (relative ratio): (m/z) 493
(mþ), 458 (mþ, ꢀCl).
IR (KBr, cmꢀ1): 1596 (vC]C), 1568 (vC]N), 1498, 1471, 1436, 1335,
815, 781, 749, 731, 695. Anal. Calcd. for C33H27N5CoCl2: C, 63.58; H,
4.37; N, 11.23. Found: C, 63.98; H, 4.19; N, 10.82. MALDIeTof for
C33H27N5Co58Cl325 (relative ratio): (m/z) 585 (mþ, ꢀCl), 549
(mþ, ꢀ2Cl).
4.3.9. 2,6-bis(10-benzylbenzimidazol-20-yl)pyridine iron(II)Cl2 (3c)
The procedure as above in (4.3.1) using L3 and FeCl2 gave 3c as
a dark blue powder in 85% yield.
IR (KBr, cmꢀ1): 3024 (vNeH), 1603 (vC]C), 1449, 1470, 1442, 1157,
4.3.16. 2,6-bis(3-methylpyrazoyl)pyridine cobalt(II)Cl2 (6b)
The procedure as above in (4.3.1) using L5 and CoCl2 gave 6b as
a blue powder in 95.1% yield.
861, 734, 696. 1H NMR (400 MHz, CDCl3):
d (ppm) 8.36 (2H, Hpyr),
8.21 (1H, Hpyr), 7.78 (2H, Hph), 7.49 (2H, Hph), 7.28 (4H, Hph), 7.16
(8H, Hph), 6.81 (2H, Hph), 5.77 (4H, eCH2Ph). Anal. Calcd. for
C33H27N5FeCl2: C, 63.89; H, 4.39; N, 11.29. Found: C, 63.63; H, 4.48;
N, 11.59. MALDIeTof for C33H27N5Fe56Cl235 (relative ratio): (m/z) 617
(mþ), 582 (mþ, ꢀCl).
IR (KBr, cmꢀ1): 3103, 3074, 1616, 1582, 1542, 1484, 1385, 1316,
1241, 1175, 1061, 983, 795, 778, 790. Anal. Calcd. for C13H13N5CoCl2:
C, 42.30; H, 3.55; N, 18.97. Found: C, 42.00; H, 3.81; N, 19.31.
MALDIeTof for C13H13N5Co58Cl325 (relative ratio): (m/z) 333
(mþ, ꢀCl).
4.3.10. 2,6-bis(pyrazoyl)pyridine iron(II)Cl2 (4a)
The procedure as above in (4.3.1) using L4 and FeCl2 gave 4a as
a yellow powder in 76.9% yield.
4.3.17. 2,6-bis(3,5-dimethylpyrazoyl)pyridine cobalt(II)Cl2 (6c)
The procedure as above in (4.3.1) using L6 and CoCl2 gave 6c as
a blue powder in 91.1% yield.
IR (KBr, cmꢀ1): 1619, 1587, 1526, 1478, 1400, 1344, 1311, 1179,
1077, 1059, 968, 782. Anal. Calcd. for C11H9N5FeCl2: C, 39.09; H,
2.68; N, 20.72. Found: C, 38.48; H, 2.52, N, 21.63.; MALDIeTof for
C11H9N5Fe56Cl235 (relative ratio): (m/z) 337 (mþ), 302 (mþ, ꢀCl).
IR (KBr, cmꢀ1): 3100, 2971, 1613, 1590, 1563, 1480, 1393, 1363,
1309, 1181, 1136, 1048, 983, 842, 788, 739. Anal. Calcd. for
C15H17N5CoCl2: C, 45.36; H, 4.31; N, 17.63. Found: C, 46.18; H, 4.12;
N,18.04. MALDIeTof for C15H17N5Co58Cl235 (relative ratio): (m/z) 361
(mþ, ꢀCl).
4.3.11. 2,6-bis(3-methylpyrazoyl)pyridine iron(II)Cl2 (4b)
The procedure as above in (4.3.1) using L5 and FeCl2 gave 4b as
a yellow powder in 92.4% yield.
4.4. Procedure for butadiene polymerization
IR (KBr, cmꢀ1): 3104, 1615, 1582, 1540, 1483, 1382, 1371, 1316,
1241, 1175, 1062, 984, 795, 776. 1H NMR (400 MHz, CDCl3):
d
(ppm)
A typical procedure for the polymerization is as follows (entry 1
in Table 5): a toluene solution of butadiene (5 mL, 2.0 mol/L) was
added to a moisture free ampere bottle preloaded with complex 1a
(5.3 mg, 0.01 mmol), then MMAO (2.0 mmol) was injected to
initiate the polymerization at 20 ꢁC. After 4 h, methanol was added
to the system to quench the polymerization. The mixture was
8.78 (2H, Hpyr), 8.04 (1H, Hpyr), 7.68 (2H, Hpyz), 6.41 (2H, Hpyz), 2.30
(6H, eCH3). Anal. Calcd. for C13H13N5FeCl2: C, 42.66; H, 3.58; N,
19.13. Found: C, 43.46; H, 3.23; N, 19.73. MALDIeTof for
C13H13N5Fe56Cl325 (relative ratio): (m/z) 365 (mþ, ꢀCl), 330
(mþ,ꢀ2Cl).